Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Afferent Pharmaceuticals' P2X3 receptor antagonist reduces bladder hyperactivity

Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.

26 Aug 2010

Wentworth-Douglass Hospital implements One Medical Passport for automation of pre-op processes

Medical Web Technologies today announced that Wentworth-Douglass Hospital, the largest acute care hospital in the Seacoast, has successfully taken its pre-operative process online with One Medical Passport. Since implementing One Medical Passport, Wentworth-Douglass has lowered operating costs, increased patient satisfaction, and reclaimed valuable nurse time.

25 Aug 2010

PTCB CPhTs to play critical role in immunization efforts at retail pharmacies nationwide

With flu season fast approaching, PTCB Certified Pharmacy Technicians will again play a critical role in immunization efforts at retail pharmacies across the country. For example, last year Walgreens successfully immunized over 7.4 million patients against H1N1 and seasonal influenza with the direct support of PTCB CPhTs.

25 Aug 2010

Stem cell therapy cures 12-year-old boy with diabetes

Cellonis Biotechnologies, a Beijing and HK-based medical research and application company, has recorded some remarkable results in the treatment of a twelve-year-old boy with diabetes using their stem cell therapy in a Beijing partner hospital. He has completely regained his normal life, enjoying sports and school activities just like every other person his age, and has been free from injections and drugs for more than half a year.

25 Aug 2010

Diarrhea, skin diseases increase among children in flood-affected areas of Pakistan: Survey

World Vision says assessments conducted over the last few days near the towns of Muzaffar Garh and Kot Addo in Punjab paint a bleak picture of the impact of the flooding. The Christian humanitarian organization says its reports from Sukkur in the Sindh Province are equally dire. Contaminated water, cramped living conditions and a lack of sanitation are contributing to a rapid increase in cases of diarrhea and skin diseases in children.

25 Aug 2010

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Celgene Corporation today announced that information was posted on the FDA Web site indicating that an Abbreviated New Drug Application (ANDA) has been received by the Office of Generic Drugs (OGD) containing a "Paragraph IV" patent certification, for REVLIMID (lenalidomide) 25 mg capsules. Celgene has not yet received the Paragraph IV notification letter identifying the filer.

25 Aug 2010

Reducing patient body temperature with cold salt beneficial for patients undergoing balloon angioplasty

Treating heart attack patients with hypothermia reduces the amount of heart damage by more than one third after balloon angioplasty. Researchers in Lund, Sweden have today released the results of a study showing that the amount of heart damage in heart attack patients whose body temperature was lower than 35˚C (95˚F) was reduced by more than one third after they were treated with balloon angioplasty to open their clogged heart vessel.

25 Aug 2010

Rock Sake traditional white spirits are gluten and sulfite free

The movement toward high quality, all natural food and drink continues to gain momentum and Americans need a cocktail that fits in with their healthy lifestyle. Rock Sake is a line of ultra-premium, domestically produced sake that is a delicious and nutritious alternative to traditional white spirits. Per ounce, Rock Sake is half the calories of vodka, rum and other white spirits and is gluten and sulfite free.

25 Aug 2010

Study finds measurable immunity to pandemic H1N1 virus in Norway population

By autumn 2009, almost half of the population of Norway had been vaccinated against the pandemic influenza A (H1N1) virus. Many had also been infected by the virus during the summer and autumn outbreaks. The majority of those who were vaccinated or were infected are expected to have developed immunity to the virus.

25 Aug 2010

Cerus to acquire BioOne's commercialization rights for INTERCEPT Blood System

Cerus Corporation announced today that it has signed an agreement to acquire BioOne Corporation's commercialization rights for the INTERCEPT Blood System for platelets and plasma, subject to approval of the transaction by BioOne's shareholders. In 2004 and 2005, Cerus and its partner at the time, Baxter International, licensed the commercialization rights for INTERCEPT platelets and plasma to BioOne for an Asian territory, which included China, Japan, Taiwan, Singapore, Korea, Thailand and Vietnam.

25 Aug 2010

Survey finds women interested in human papillomavirus vaccination

Cost but not convenience plays a significant role in attitudes about vaccination for common human papillomaviruses for women over the age of 26, according to the authors of a recent article in the journal Sexual Health.

25 Aug 2010

Advanced Life Sciences seeks government funding for development of Restanza antibiotic

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced plans to seek additional government funding for development of its novel, once-daily antibiotic, Restanza.

25 Aug 2010

Researchers develop high-resolution technology to visualize individual virus particles

In the war against infectious disease, identifying the culprit is half the battle. Now, research professor Shaopeng Wang and his colleagues from the Biodesign Institute at Arizona State University, describe a new method for visualizing individual virus particles. Their research opens the door to a more detailed understanding of these minute pathogens, and may further the study of a broad range of micro- and nanoscale phenomena.

25 Aug 2010

Also in Global Health News: IDUs in Kenya; Haiti recovery; Pandemic preparedness; Somalia hunger; HIV in Mozambique; Strengthening immune system against HIV

In Kenya, "[i]ntravenous drug users (IDUs) have been largely ignored by the government's HIV programmes on the basis that drug-taking is illegal, but a new policy is being drafted with the aim of reducing HIV transmission among this high-risk group," IRIN/PlusNews reports. The article includes comments from Nicholas Muraguri, head of the National AIDS and Sexually Transmitted Infections Control Programme, who said that the policy would treat drug use as a health issue, not a criminal one.

25 Aug 2010

UNT Health Science Center analyzes DNA from unidentified human remains

Center for Human Identification at the University of North Texas Health Science Center (UNTHSC) analyzes DNA from unidentified human remains for law enforcement organizations and medical examiners across the country in an attempt to put a name to a body or victim. The result, in many cases, is resolution for family members who have spent years wondering about the fate of their loved one.

24 Aug 2010

Hemispherx Biopharma enters agreement to settle pending securities class actions

Hemispherx Biopharma, Inc. today announced that, as result of court mediation proceedings, it has entered into a written agreement in principle with the Court-appointed lead plaintiffs to settle all of the currently pending securities class actions consolidated in the U.S. District Court for the Eastern District of Pennsylvania.

24 Aug 2010

Department of Health to hold vaccination drive for whooping cough

With some areas of the state seeing an increase in whooping cough, known medically as pertussis, the Department of Health urges all Pennsylvanians to ensure they are protected against the vaccine-preventable disease.The department will soon hold public vaccination clinics in York and Delaware counties, where cases of pertussis have been rising.

24 Aug 2010

Medivir appoints Daewoong as South Korean distributor for Xerclear

Medivir AB today announced it has appointed Daewoong Pharmaceutical Co. Ltd. as its exclusive distributor for Xerclear™ in South Korea. Under the terms of the agreement, Daewoong will be responsible for obtaining the regulatory approvals, and for marketing, sales and distribution of Medivir's cold sore product in the territory. In consideration of the rights granted to Daewoong, Medivir will receive upfront and milestone payments and royalties on sales according to a profit sharing scheme.

24 Aug 2010

Baxter announces definitive agreement with Kamada for GLASSIA alpha1-proteinase inhibitor

Baxter International Inc. today announced a definitive agreement with Kamada Ltd. for exclusive commercial rights to GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid alpha1-proteinase inhibitor, in the United States, Australia, New Zealand and Canada.

From Baxter International Inc. 24 Aug 2010

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.

24 Aug 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Afferent Pharmaceuticals' P2X3 receptor antagonist reduces bladder hyperactivity

Wentworth-Douglass Hospital implements One Medical Passport for automation of pre-op processes

PTCB CPhTs to play critical role in immunization efforts at retail pharmacies nationwide

Stem cell therapy cures 12-year-old boy with diabetes

Diarrhea, skin diseases increase among children in flood-affected areas of Pakistan: Survey

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Reducing patient body temperature with cold salt beneficial for patients undergoing balloon angioplasty

Rock Sake traditional white spirits are gluten and sulfite free

Study finds measurable immunity to pandemic H1N1 virus in Norway population

Cerus to acquire BioOne's commercialization rights for INTERCEPT Blood System

Survey finds women interested in human papillomavirus vaccination

Advanced Life Sciences seeks government funding for development of Restanza antibiotic

Researchers develop high-resolution technology to visualize individual virus particles

Also in Global Health News: IDUs in Kenya; Haiti recovery; Pandemic preparedness; Somalia hunger; HIV in Mozambique; Strengthening immune system against HIV

UNT Health Science Center analyzes DNA from unidentified human remains

Hemispherx Biopharma enters agreement to settle pending securities class actions

Department of Health to hold vaccination drive for whooping cough

Medivir appoints Daewoong as South Korean distributor for Xerclear

Baxter announces definitive agreement with Kamada for GLASSIA alpha1-proteinase inhibitor

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in